Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Public ClinicalTrials.gov record NCT01659021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Controlled Study Evaluating the Efficacy and Safety of Idelalisib (GS-1101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the effect of the addition of idelalisib to ofatumumab on progression-free survival (PFS) in participants with previously treated chronic lymphocytic leukemia (CLL).
Study identification
- NCT ID
- NCT01659021
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 261 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 4, 2012 (Actual)
- Primary completion
- Aug 15, 2018 (Actual)
- Completion
- Aug 15, 2018 (Actual)
- Last update posted
- Aug 14, 2019
2012 – 2018
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | — |
| California Cancer Associates for Research and Excellence (CCARE) | Fresno | California | 93720 | — |
| Kaiser Permanente | San Diego | California | 92120 | — |
| Coastal Integrative Cancer Care | San Luis Obispo | California | 93401 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| Kaiser Permanente Vallejo Medical Center | Vallejo | California | 94589 | — |
| Kaiser Permanente of Colorado | Denver | Colorado | 80205 | — |
| Saint Mary's Regional Cancer Center | Grand Junction | Colorado | 81501 | — |
| Cancer Specialists of North Florida | Jacksonville | Florida | 32256 | — |
| Georgia Regents University | Augusta | Georgia | 30912 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| Center for Cancer and Blood Disorders, PC | Bethesda | Maryland | 20817 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Washington University Medical Center | St Louis | Missouri | 63110-1010 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Weill Cornell Medical Center | New York | New York | 10065 | — |
| Oncology Hematology Care, Inc. | Cincinnati | Ohio | 45242 | — |
| The Ohio State University Medical Center | Columbus | Ohio | 43202 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Upstate Oncology Associates | Greenville | South Carolina | 29601 | — |
| Tennessee Oncology, PLLC | Chattanooga | Tennessee | 37404 | — |
| Tenessee Oncology, PLLC | Nashville | Tennessee | 37203-1781 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01659021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 14, 2019 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01659021 live on ClinicalTrials.gov.